Safety Alerts and Recalls IBS-C Treatment Zelnorm Withdrawn From the Market Again By Brian Park, PharmD Publish Date June 30, 2022
Safety Alerts and Recalls OTC Laxative Recalled Due to Microbial Contamination By Diana Ernst, RPh Publish Date June 24, 2022
News Skyrizi Approved for Moderately to Severely Active Crohn Disease By Brian Park, PharmD Publish Date June 21, 2022
News Amvuttra Approved for Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis By Brian Park, PharmD Publish Date June 14, 2022
News Safety, Efficacy of Oral Microbiome Therapeutic Confirmed in Recurrent CDI Study By Brian Park, PharmD Publish Date June 10, 2022
Safety Alerts and Recalls Antacid, Constipation Products Recalled Due to Microbial Contamination By Brian Park, PharmD Publish Date June 10, 2022
Drugs in the Pipeline May 2022: Drug Pipeline Updates By Brian Park, PharmD Publish Date June 9, 2022
News Opdivo-Based Regimens Approved as First-Line Treatments for Esophageal Cancer By Brian Park, PharmD Publish Date June 1, 2022
Drugs in the Pipeline Ervogastat/Clesacostat Fast Tracked for Nonalcoholic Steatohepatitis By Diana Ernst, RPh Publish Date May 26, 2022
Drugs in the Pipeline FDA to Review Vonoprazan for Erosive Esophagitis By Diana Ernst, RPh Publish Date May 25, 2022
News Dupixent Gets FDA Approval for Eosinophilic Esophagitis By Brian Park, PharmD Publish Date May 20, 2022
Drugs in the Pipeline Upadacitinib Meets Endpoints in Crohn Disease Maintenance Trial By Brian Park, PharmD Publish Date May 11, 2022
Drugs in the Pipeline Durvalumab Plus Chemo Granted Priority Review for Biliary Tract Cancer By Brian Park, PharmD Publish Date May 4, 2022
News Voquezna Triple, Dual Pak Approved for H. Pylori Infection Treatment By Brian Park, PharmD Publish Date May 4, 2022
News Zerbaxa Approved for Complicated Pediatric Intra-abdominal, Urinary Tract Infections By Brian Park, PharmD Publish Date April 26, 2022
News WHO Says Acute Hepatitis Cases in Children Now Reported in 11 Countries Publish Date April 26, 2022
News No Increased Risk for Appendicitis Reported With mRNA COVID-19 Vaccination Publish Date April 26, 2022
Drugs in the Pipeline Combo Immunotherapy Gets Priority Review for Advanced Liver Cancer By Diana Ernst, RPh Publish Date April 25, 2022